Research from Synlogic, a biotech company founded by Profs James Collins and Timothy Lu, has found that it’s the company’s engineered bacteria could provide some benefit to patients with a rare genetic disease, reports Emily Mullin for Wired. “Similar to how you might program a computer, we can tinker with the DNA of bacteria and have them do things like produce a drug at the right time and the right place, or in this case, break down a toxic metabolite,” says Lu.
Researchers at MIT are working on a system that can track the development of Parkinson’s disease by monitoring a person’s gait speed, reports Kyle Wiggers and Devin Coldewey for TechCrunch. “The MIT Parkinson’s-tracking effort aims to help clinicians overcome challenges in treating the estimated 10 million people afflicted by the disease globally,” writes Wiggers and Coldewey.
Forbes contributor Marija Butkovic spotlights Gloria Ro Kolb ’94, the founder of medical device company Elidah, which is developing “an external, home-use treatment for female urinary incontinence.”
Spatial Equity NYC, an online tool developed by MIT researchers and Transportation Alternatives, uses public information to address the racial and economic disparities between neighborhoods in New York City, reports Jenna Deangelis for CBS News. “Our team has focused on fostering data transparency, making open data more accessible, legible and useable,” says research associate Daniela Coray.
Researchers from MIT and Transportation Alternatives have developed an online tool using census information, city health data, and other public information to help understand the correlation between racial and health care disparities in New York City, reports Stephen Nessen for Gothamist. The researchers have found that “the New York City neighborhoods with the worst health and poverty outcomes, also tend to have more injuries from traffic,” writes Nessen.
Researchers from MIT and Harvard Medical School are investigating how exercise and high-fat diets can alter cells, genes and cellular pathways, reports Abby Patkin for Boston.com. “Their research could eventually help develop drugs that would mimic the effects of exercise and combat obesity,” explains Patkin.
Researchers from MIT and Harvard Medical School have conducted a study to see how exercise and high-fat diets can impact cells, reports WCVB. The researchers “say the data could eventually be used to develop drugs that could help enhance or mimic the benefits of exercise,” writes WCVB.
A new study by researchers from MIT and Harvard Medical School has helped identify the impact of exercise and high-fat diets on cells, reports Darren Botelho for NBC Boston 10. “Years from now, those researchers say the data could lead to a pill that would help not only with weight loss, but with the overall effect from exercise – a better wellbeing,” explains Botelho.
Prof. Manolis Kellis speaks with Boston 25 about his team’s work exploring the underlying mechanisms exploring how exercise influences weight loss, findings that could offer potential targets for drugs that could help to enhance or mimic the benefits of exercise. “Such an intervention would be a complete game changer and the reason for that is that the obesity epidemic has led to the U.S. having a decreased life span compared to all other developed countries,” says Kellis.
MIT researchers have developed a new in-home device that can help monitor Parkinson’s patients by tracking their gait, reports Hiawatha Bray for The Boston Globe. “We know very little about the brain and its diseases,” says Professor Dina Katabi. “My goal is to develop non-invasive tools that provide new insights about the functioning of the brain and its diseases.”
Popular Science reporter Philip Kiefer writes that MIT researchers have developed an in-home device that could be used to track the progression of symptoms in Parkinson’s patients. “We can’t really ask patients to come to the clinic every day or every week,” explains graduate student Yingcheng Liu. “This technology gives us the possibility to continuously monitor patients, and provide more objective assessments.”
Lindsay Androski ’98, a full-term member of the MIT Corporation, writes an opinion piece for The Los Angeles Times about the how the lack of diversity in healthcare negatively impacts women and people of color. “The people in charge of funding healthcare research and development ultimately shape which conditions will be treated and cured,” writes Androski. “Every day the status quo continues means more suffering, mainly for people who aren’t white men.”
Graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, explore the impact that Covid-19 has had on the workforce, reports Sarah Todd for Quartz. “People ages 65 and up are more likely to leave the workforce after contracting Covid compared to younger people,” say Soltas and Goda.
A study by graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, underlines the pandemic’s impact on labor supply in the United States, reports Richard Luscombe for The Guardian. “Our estimates suggest Covid-19 illnesses have reduced the US labor force by approximately 500,000 people,” say Soltas and Goda.
A study by graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, explores the economic toll of Covid-19, including acute illness and long Covid, reports Erin Prater for Fortune. The paper “also looks at the impact of other Covid-related medical consequences like organ damage, mental health issues, new kidney and heart problems, and the worsening of preexisting illness, in addition to the phenomenon of Covid forcing older workers into early retirement,” explains Prater.